Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanowear’s SimpleSense platform is FDA-cleared and provides continuous, clinical-grade cardiopulmonary data from a non-invasive wearable undergarment. It replaces multiple traditional diagnostic tools by capturing over 85 medical-grade biomarkers per millisecond. The system is used for home-based patient monitoring and in decentralized clinical trials to improve efficiency and outcomes. No specific drug or therapeutic trial results are reported; the company’s focus is on device-enabled diagnostics rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanowear.